Designating October 23, 2024, as "AADC Deficiency Awareness Day".

Legislation Details

Designates October 23, 2024, as “AADC Deficiency Awareness Day.”
Acknowledges that rare diseases affect fewer than 200,000 people in the U.S. at any given time, with over 7,000 rare diseases impacting 25 to 30 million people.
Notes that children represent more than half of those living with rare diseases.
Describes Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency as a genetic neurologic rare disease that severely impacts development, motor skills, and cognitive abilities.
States that AADC Deficiency is caused by a lack of the AADC enzyme necessary for dopamine production, hindering basic life functions and motor milestones.
Mentions that diagnosis is made through genetic and biochemical tests.
Lists symptoms of AADC Deficiency, including low muscle tone, developmental delays, and involuntary eye movements.
Reports approximately 200 cases of AADC Deficiency worldwide and notes its frequent misdiagnosis as other conditions.
Emphasizes the role of Congress in raising awareness of AADC Deficiency among the public and medical community.
Highlights that increased awareness can help patients recognize symptoms and seek appropriate treatment.
Calls for improved education and representation for individuals affected by AADC Deficiency.